Immunological biomarkers of tuberculosis
Top Cited Papers
- 8 April 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Immunology
- Vol. 11 (5), 343-354
- https://doi.org/10.1038/nri2960
Abstract
Currently there are no sufficiently validated biomarkers to aid the evaluation of new tuberculosis vaccine candidates, the improvement of tuberculosis diagnostics or the development of more effective and shorter treatment regimens. To date, the detection of Mycobacterium tuberculosis or its products has not been able to adequately address these needs. Understanding the interplay between the host immune system and M. tuberculosis may provide a platform for the identification of suitable biomarkers, through both unbiased and targeted hypothesis-driven approaches. Here, we review immunological markers, their relation to M. tuberculosis infection stages and their potential use in the fight against tuberculosis. © 2011 Macmillan Publishers Limited. All rights reserved.RevieKeywords
This publication has 99 references indexed in Scilit:
- Rapid Molecular Detection of Tuberculosis and Rifampin ResistanceThe New England Journal of Medicine, 2010
- CD4+Regulatory T Cells in a Cynomolgus Macaque Model ofMycobacterium tuberculosisInfectionThe Journal of Infectious Diseases, 2010
- An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosisNature, 2010
- Dynamic antibody responses to the Mycobacterium tuberculosis proteomeProceedings of the National Academy of Sciences of the United States of America, 2010
- Programmed death-1 (PD-1)–deficient mice are extraordinarily sensitive to tuberculosisProceedings of the National Academy of Sciences of the United States of America, 2010
- Activity-Based Metabolomic Profiling of Enzymatic Function: Identification of Rv1248c as a Mycobacterial 2-Hydroxy-3-oxoadipate SynthaseCell Chemical Biology, 2010
- Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnosticsProceedings of the National Academy of Sciences of the United States of America, 2009
- From differentiating metabolites to biomarkersAnalytical and Bioanalytical Chemistry, 2009
- Delayed protection by ESAT-6–specific effector CD4+ T cells after airborne M. tuberculosis infectionThe Journal of Experimental Medicine, 2008
- Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania majorNature Medicine, 2007